AVANTI POLAR LIPIDS INC has a total of 38 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are JINLING PHARMACEUTICAL CO LTD, WANG ZHISEN and PELLFICURE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | China | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Canada | 3 | |
#7 | Hong Kong | 2 | |
#8 | Japan | 2 | |
#9 | Israel | 1 | |
#10 | India | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Burgess Stephen W | 31 |
#2 | Li Shengrong | 31 |
#3 | Shaw Walter A | 27 |
#4 | Hickman David T | 12 |
#5 | Lopez-Deber Maria Pilar | 12 |
#6 | Shaw Walter | 6 |
#7 | Majeed Muhammed | 2 |
#8 | Goldman Corey K | 2 |
#9 | Stephen W Burgess | 2 |
#10 | Maria Pilar Lopez-Deber | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020247680A2 | Universal lipid quantitative standards for use in lipidomics | |
US2020306274A1 | Novel therapies for treating and preventing chronic rhinosinusitis | |
US2017349618A1 | Disaccharide synthetic lipid compounds and uses thereof | |
AU2015301952A1 | Oral composition for delivery of drugs and other substances | |
AU2015269699A1 | Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies | |
US2016024001A1 | Novel compounds | |
US2015110854A1 | Disaccharide synthetic lipid compounds and uses thereof | |
US2013273149A1 | Disaccharide synthetic lipid compounds and uses thereof | |
US2014275591A1 | Compounds | |
AU6978198A | Cationic polymers for nucleic acid transfection |